BEWICK CRESCENT SURGERY
27 BEWICK CRESCENT, NEWTON AYCLIFFE
CHD 14
The percentage of patients with a history of myocardial infarction (from 1 April 2011) currently treated with an ACE inhibitor (or ARB if ACE intolerant), aspirin or an alternative anti-platelet therapy, beta blocker and statin (unless a contraindication or side effects are recorded)
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| CHD 11 | 2005 | 28 | 34 | 82.4% | |
| CHD 11 | 2006 | 41 | 47 | 87.2% | |
| CHD 11 | 2007 | 55 | 61 | 90.2% | |
| CHD 11 | 2008 | 71 | 77 | 92.2% | |
| CHD 11 | 2009 | 70 | 75 | 93.3% | |
| CHD 11 | 2010 | 70 | 74 | 94.6% | |
| CHD 11 | 2011 | 69 | 72 | 95.8% | |
| CHD 14 | 2012 | 5 | 5 | 100.0% | |
| CHD 14 | 2013 | 6 | 6 | 100.0% | |
| CHD006 | 2014 | 14 | 14 | 100.0% | |
| CHD006 | 2015 | 21 | 22 | 95.5% |
